Thank you for speaking with us at The Liver Meeting®
Posted: November 14, 2019
We enjoyed speaking with you at
The Liver Meeting®
Thank you for taking a few minutes to discuss our panels of biomarkers for NAFLD, NASH, AH, and DILI research, featuring CK18.
These CK18 mechanistic biomarkers provide insight into the biological processes occurring during liver injury.
- M30 Apoptosense®
- M65 EpiDeath®
- M65 ELISA®
- M65 EpiRat ELISA® – New! Ask us about evaluating a research lot
Learn more about these and additional biomarkers for liver and metabolic disease research and drug development, like:
– Soluble CD163 (sCD163)
– Mac-2 Binding Protein (M2BP)
– Collagen IV
– Hyaluronic Acid (HA)
– FGF19 / FGF21
– Insulin, C-peptide, Intact Proinsulin
at diapharma.com. Feel free to contact us or your Territory Manager.
- Michael Hambleton, Ph.D.
- Jessica Tuohy, Ph.D.
- Jennifer Kiblinger
- Tinu Adewole
Research use only in the U.S. and Canada